James Virgin

Papers

Total Citations

H-Index

About

James Virgin is a leading urologic oncology researcher whose work centers on improving surgical outcomes for prostate cancer patients, with a particular focus on the prognostic significance of positive surgical margins after radical prostatectomy. His most impactful contribution is a landmark network meta-analysis that systematically compared how the anatomical location of a positive margin—whether at the apex, bladder neck, or posterolateral region—differentially affects the risk of biochemical recurrence. This study, published in 2025 and already garnering 11 citations, provides surgeons with evidence-based guidance for tailoring postoperative surveillance and adjuvant therapy decisions. Virgin’s research bridges a critical gap between surgical pathology and clinical management, offering a nuanced understanding that moves beyond the binary presence-or-absence of a margin. By synthesizing data from multiple comparative studies, his work has helped standardize reporting and risk stratification in prostate cancer care. His findings are increasingly cited in clinical guidelines and have sparked further investigation into margin-directed radiotherapy. For students and clinicians alike, Virgin’s scholarship exemplifies how meticulous meta-analytic methods can translate complex surgical variables into actionable insights that directly impact patient outcomes.